Aghourian, M
Legault-Denis, C
Soucy, J-P
Rosa-Neto, P http://orcid.org/0000-0001-9116-1376
Gauthier, S
Kostikov, A
Gravel, P
Bédard, M-A
Article History
Received: 27 February 2017
Revised: 17 July 2017
Accepted: 20 July 2017
First Online: 12 September 2017
Competing interests
: M-AB reports personal fees from Pfizer Canada, Shire Pharma, Purdue Pharma, and Merck Canada, outside the submitted work. PRN reports personal fees from Lilly and TauRx pharmaceuticals, outside the submitted work. Serge Gauthier reports personal fees from Lilly, Merck Canada, Lundbeck, Novartis and Pfizer Canada, outside the submitted work. The remaining authors declare no conflict of interest.